• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Dermavant

Anonymous board for Dermavant
Replies
32
Views
6K
anonymous
Replies
2
Views
363
anonymous
Replies
33
Views
2K
anonymous
Replies
13
Views
2K
anonymous
Replies
18
Views
2K
anonymous
Replies
5
Views
1K
anonymous
Replies
25
Views
4K
anonymous
Replies
7
Views
2K
EyesOnKev
Replies
8
Views
1K
anonymous
Replies
4
Views
2K
anonymous
Replies
18
Views
3K
anonymous